Skip to main content
  • Vektor Medical, Inc.
  • Investment: 2024
  • Status: Active

Vektor Medical is advancing care for arrhythmia patients by unlocking insights contained in a standard ECG. Through its AI-based, non-invasive arrhythmia analysis technology, vMap®, the company aims to improve cardiac ablation outcomes, optimize workflows and increase procedural efficiency. vMap® is the only FDA-cleared, non-invasive AI-based solution for arrhythmia localization and analysis, seamlessly leveraging only a 12-lead ECG.

 

Involved Team

Dr. Luc Marengère
Managing Partner
Dr. Sascha Berger
General Partner,
Munich

Rob Krummen, (CEO)